Dr Ross Ryan Moquin, MD | |
739 Irving Ave Ste 600, Syracuse, NY 13210-1663 | |
(315) 701-2550 | |
(315) 701-2551 |
Full Name | Dr Ross Ryan Moquin |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 739 Irving Ave Ste 600, Syracuse, New York |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1821093279 | NPI | - | NPPES |
02809254 | Medicaid | NY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | 240707 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Ross Ryan Moquin, MD 1001 W Fayette St, Suite 400, Syracuse, NY 13204-2859 Ph: (315) 475-3999 | Dr Ross Ryan Moquin, MD 739 Irving Ave Ste 600, Syracuse, NY 13210-1663 Ph: (315) 701-2550 |
News Archive
According to a study published today in PLOS Pathogens, children who live in regions of the world where malaria is common can mount an immune response to infection with malaria parasites that may enable them to avoid repeated bouts of high fever and illness and partially control the growth of malaria parasites in their bloodstream.
The Los Angeles Times explores some key questions: Will insurers continue to raise premiums; when will the Medicare "doughnut hole" close; and, "how do I sign up for my new insurance?" In answer to the last one, the Times writes, "Although there are some provisions that take effect this year, such as bans on lifetime limits and the denial of coverage to children with pre-existing conditions, the part of the bill that provides new insurance options does not take effect until 2014" (Geiger, 3/28).
Advanced Bionics agreed to settle an administrative complaint arising from a disagreement with the U.S. Food and Drug Administration (FDA).
ZyStor Therapeutics, Inc., a biotechnology company developing a new class of targeted protein therapeutics for the treatment of Lysosomal Storage Diseases using the Company's proprietary Glycosylation Independent Lysosomal Targeting technology, today announced that it has received clearance from the U. S. Food and Drug Administration to proceed into a clinical trial for its first drug candidate, ZC-701, an enzyme replacement therapy for the treatment of Pompe disease.
Light-sensing cells in the eye rely on their outer segment to convert light into neural signals that allow us to see. But because of its unique cylindrical shape, the outer segment is prone to breakage, which can cause blindness in humans. A study published by Cell Press on January 22nd in the Biophysical Journal provides new insight into the mechanical properties that cause the outer segment to snap under pressure.
› Verified 5 days ago
Lawrence S Chin, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 725 Irving Ave, Ste. 503, Syracuse, NY 13210 Phone: 315-464-4470 Fax: 315-464-5520 | |
Dr. Jorge Luis Eller, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 739 Irving Ave Ste 600, Syracuse, NY 13210 Phone: 315-701-2550 Fax: 315-701-2551 | |
David Y Eng, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 739 Irving Ave Ste 600, Syracuse, NY 13210 Phone: 315-701-2550 | |
Michael P Owen, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 475 Irving Ave, Suite 418, Syracuse, NY 13210 Phone: 315-475-3999 Fax: 315-470-4014 | |
Zulma Sarah Tovar Spinoza, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 725 Irving Ave, Ste. 503, Syracuse, NY 13210 Phone: 315-464-4470 Fax: 315-464-5520 | |
Satish Krishnamurthy, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 725 Irving Ave, Ste. 503, Syracuse, NY 13210 Phone: 315-464-4470 Fax: 315-464-5520 | |
Dr. Ali Hazama, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-1800 |